Resources from the same session
How do we pick a recommended dose: Safe may be, but optimised?
Presenter: Elena Garralda
Session: Workshop in collaboration with ESMO YOC: Evaluation of phase I data at the end of the study for next planning of drug development
Resources:
Slides
Webcast
Early evaluation of efficacy in phase I trials: Persevere or halt the programme?
Presenter: Jordi Rodon
Session: Workshop in collaboration with ESMO YOC: Evaluation of phase I data at the end of the study for next planning of drug development
Resources:
Slides
Webcast